Document is current
Any future updates will be listed below
-
Authors
Geer, Eliza B.
Clemmons, David R.
Sisco, Jill
Koobatian, Maxwell
Okeyo, Janetricks C.
Quock, Tiffany P.
Wang, Yang
Colzani, Raffaella
Krasner, Alan
-
Funding
Funding for this research was provided by:
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
Crinetics Pharmaceuticals Inc (This study was funded by Crinetics Pharmaceuticals Inc)
- License Information
-
More Information
Article History
Received: 19 March 2026
Accepted: 7 July 2026
First Online: 23 July 2026
Declarations
Competing interests: E.B.G. reports serving as a consultant for Camurus, Crinetics Pharmaceuticals, Inc., HRA Pharma/Esteve, Recordati, and Xeris; and serving as an investigator for research grants to MSKCC from Recordati and Sparrow; she is an Associate Editor for Pituitary and played no role in the Journal’s evaluation of this manuscript. D.R.C reports serving as a consultant for AstraZeneca, Crinetics Pharmaceuticals, Inc., and Novo Nordisk. J.S. reports serving as a consultant for Alexion, Camurus, Chiesi, Debiopharm, and Recordati; and serving on advisory boards for Crinetics Pharmaceuticals, Inc., and Pfizer. M.K. and T.P.Q. were employees of Crinetics Pharmaceuticals, Inc., at the time this work was conducted. J.C.O., Y.W., R.C., and A.K. are employees and shareholders of Crinetics Pharmaceuticals, Inc.
